This year’s programme brings together the most clinically and scientifically relevant topics in primary liver cancer, covering everything from basic and translational research to evidence‑based management of hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA). Our line‑up of speakers will share the latest advances in surveillance, diagnostics, treatment strategies, and survivorship across the entire disease spectrum.
You can expect an international, multidisciplinary faculty who will not only deliver comprehensive presentations but also lead meaningful discussions aimed at deepening scientific understanding, improving clinical practice, and highlighting unmet needs in the field. Sessions will be highly interactive and designed to encourage open, thoughtful dialogue on current controversies, methodological challenges, and future research directions in liver cancer